| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| norethisterone | Tablet, uncoated | 350 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 11/04/2025 |
| tramadol hydrochloride | Capsule | 50 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| sumatriptan succinate | Tablet, film coated | 140 mg | Current | Unavailable | Manufacturing | 11/04/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| ramipril | Capsule, hard | 5 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Anticipated | Available | Manufacturing | 11/04/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 11/04/2025 |
| sulfamethoxazole~trimethoprim | Injection, concentrated | 80 mg/mL~16 mg/mL | Current | Limited Availability | Manufacturing | 11/04/2025 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 11/04/2025 |
| perindopril erbumine | Tablet | 8 mg | Anticipated | Available | Manufacturing | 11/04/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| risperidone | Tablet, film coated | .5 mg | Anticipated | Available | Manufacturing | 11/04/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 11/04/2025 |
| metoprolol succinate | Tablet, modified release | 23.75 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 11/04/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 11/04/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Manufacturing | 11/04/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 11/04/2025 |
| isavuconazonium sulfate | Capsule, hard | 186.3 mg | Anticipated | Available | Manufacturing | 11/04/2025 |
| deferasirox | Tablet, film coated | 360 mg | Anticipated | Available | Manufacturing | 11/04/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.844 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Current | Limited Availability | Manufacturing | 11/04/2025 |
| Fremanezumab | Injection, solution | 225 mg | Anticipated | Available | Unexpected increase in consumer demand | 11/04/2025 |
| perindopril arginine | Tablet, film coated | 2.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/04/2025 |
| perindopril arginine | Tablet, film coated | 5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/04/2025 |
| perindopril arginine | Tablet, film coated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/04/2025 |
| cisplatin | Injection, solution | 1 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 11/04/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 11/04/2025 |
| salbutamol sulfate | Inhalation, conventional | 3 mg | Current | Unavailable | Manufacturing | 10/04/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate | Injection, solution | 22.7 microgram/mL~21.3 mg/mL | Current | Unavailable | Manufacturing | 10/04/2025 |
| clomipramine hydrochloride | Tablet, film coated | 25 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| hydroxocobalamin chloride | Injection, solution | 1 mg/mL | Resolved | Available | Manufacturing | 10/04/2025 |
| letrozole | Tablet, film coated | 2.5 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| propofol | Injection, emulsion | 10 g/L | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 10/04/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 10/04/2025 |
| Follitropin alfa | Injection, solution | 75 IU | Current | Unavailable | Manufacturing | 10/04/2025 |
| Follitropin alfa | Injection, solution | 150 IU | Current | Unavailable | Manufacturing | 10/04/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Resolved | Available | Manufacturing | 10/04/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| celecoxib | Capsule, hard | 100 mg | Current | Unavailable | Manufacturing | 10/04/2025 |
| deferasirox | Tablet, film coated | 90 mg | Anticipated | Available | Manufacturing | 10/04/2025 |
| methotrexate | Tablet | 2.5 mg | Resolved | Available | Manufacturing | 10/04/2025 |
| naproxen | Tablet, uncoated | 250 mg | Anticipated | Available | Manufacturing | 10/04/2025 |
| gemfibrozil | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 10/04/2025 |
| tobramycin | Injection, solution | 40 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 10/04/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Current | Limited Availability | Manufacturing | 10/04/2025 |
| fenofibrate | Tablet, film coated | 145 mg | Resolved | Available | Manufacturing | 9/04/2025 |
| clonazepam | Oral Liquid, solution | 2.5 mg/mL | Anticipated | Available | Manufacturing | 9/04/2025 |
| vinblastine sulfate | Injection, solution | 1 mg/mL | Resolved | Available | Manufacturing | 9/04/2025 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 9/04/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 41.363 mg~10 mg | Resolved | Available | Manufacturing | 9/04/2025 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Resolved | Available | Manufacturing | 9/04/2025 |
| quinagolide hydrochloride | Tablet, uncoated | .0819 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 9/04/2025 |
| timolol maleate | Eye Drops, solution | 6.84 mg/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 9/04/2025 |
| dorzolamide hydrochloride | Eye Drops, solution | 22.26 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 9/04/2025 |
| primidone | Tablet, uncoated | 250 mg | Current | Limited Availability | Manufacturing | 8/04/2025 |
| lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate | Injection, solution | 10 mg/mL~9.1 microgram/mL | Resolved | Available | Commercial Changes / Commercial viability | 8/04/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 10 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| naproxen | Oral Liquid, suspension | 25 mg/mL | Anticipated | Available | Manufacturing | 8/04/2025 |
| paclitaxel | Injection, concentrated | 300 mg | Current | Limited Availability | Manufacturing | 8/04/2025 |
| prilocaine hydrochloride~felypressin | Injection, solution | 30 mg/mL~.54 microgram/mL | Current | Unavailable | Manufacturing | 8/04/2025 |
| pemetrexed disodium | Injection, powder for | 551.4 mg | Current | Limited Availability | Manufacturing | 8/04/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Resolved | Available | Manufacturing | 8/04/2025 |
| mesalazine | Tablet, enteric coated | 250 mg | Current | Unavailable | Manufacturing | 8/04/2025 |
| busulfan | Injection, concentrated | 60 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| enoxaparin sodium | Injection, solution | 80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/04/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 30 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Anticipated | Available | Manufacturing | 8/04/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 8/04/2025 |
| methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 7/04/2025 |
| salbutamol sulfate | Inhalation, conventional | 6 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 7/04/2025 |
| oxytocin | Injection, solution | 10 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 7/04/2025 |
| buprenorphine hydrochloride | Injection, solution | 324 microgram/mL | Current | Unavailable | Manufacturing | 7/04/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Anticipated | Available | Manufacturing | 7/04/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
| escitalopram oxalate | Tablet, film coated | 25.548 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
| dulaglutide | Injection, solution | 1.5 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
| flecainide acetate | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Anticipated | Available | Manufacturing | 7/04/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 7/04/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~12.5 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~25 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 25 mg~40 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| dasatinib | Tablet, film coated | 20 mg | Resolved | Available | Unexpected increase in consumer demand | 7/04/2025 |
| pegaspargase | Solution, powder for | 750 U/mL | Current | Limited Availability | Manufacturing | 7/04/2025 |
| risperidone | Tablet, film coated | 2 mg | Resolved | Available | Manufacturing | 7/04/2025 |
| risperidone | Tablet, film coated | 4 mg | Resolved | Available | Manufacturing | 7/04/2025 |
| latanoprost~timolol maleate | Eye Drops, solution | .05 mg/mL~6.83 mg/mL | Resolved | Available | Manufacturing | 7/04/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 82.725 mg~10 mg | Current | Unavailable | Manufacturing | 7/04/2025 |
| potassium chloride | Injection, concentrated | 75 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 7/04/2025 |
| ethanol absolute~carmustine | Diluent, not applicable~Injection, powder for | 3 mL~100 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/04/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
| alprazolam | Tablet, uncoated | 2 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
| mirtazapine | Tablet, film coated | 30 mg | Current | Limited Availability | Manufacturing | 7/04/2025 |
2025年4月14日